title: Mesenchymal stromal cells for treatment of arthritis.
abstract: Patients with refractory inflammatory arthritis can still respond favourable to autologous haematopoietic stem cell transplantation. However, this treatment has a high morbidity and even 5% mortality. Mesenchymal stromal cells (MSC), a subset of the non-haematopoietic stromal cells obtained from bone marrow, were found to have a strong immunosuppressive effect. MSC treatment is explored in many diseases like diabetes, SLE, MS and RA. This review covers all relevant literature regarding MSC treatment of inflammatory arthritis (RA and JIA). This review contains data of in vitro studies, animal studies and clinical studies. The following subjects will be discussed in detail: properties of MSC, presence of MSC in the joint, intra-articular versus intravenous route, autologous versus allogeneic, ideal source of MSC, distribution, transdifferentiation, engraftment, rejection, efficacy and toxicology. After reading this review the reader will be totally updated in this quickly evolving field of MSC therapy.
authors.affiliation: Pediatric Immunology, Wilhelmina Children's Hospital/UMC Utrecht, Netherlands.
authors.forename: J F
authors.initials: JF
authors.lastname: Swart
authors.affiliation: Pediatric Immunology, Wilhelmina Children's Hospital/UMC Utrecht, Netherlands. Electronic address: N.Wulffraat@umcutrecht.nl.
authors.forename: N M
authors.initials: NM
authors.lastname: Wulffraat
mesh_terms: D000818:Animals; D001168:Arthritis / Q000601:surgery*; D006801:Humans; D045164:Mesenchymal Stem Cell Transplantation / Q000379:methods*
keywords: Arthritis; Juvenile arthritis; Mesenchymal; Mesenchymal stem cell; Mesenchymal stromal cell; Rheumatoid arthritis